September 2019

Thursday, September 5th, 2019

CONTINUUS Pharmaceuticals Raises $5 M in Series B Round, Led by Mark Bamforth Who Will Join the Board of Directors

We are happy to announce that we completed a $5 M Series B financing. This round was led by Mark Bamforth, President & CEO at Arranta Bio, with participation by IMA and other investors from previous rounds. Bamforth will also…